Access
This article is part of Nature's premium content.
Published online 27 January 2009 | 457, 520-521 (2009) | doi:10.1038/457520a
News
Pfizer to buy Wyeth in $68-billion deal
Drug giant chases stake in biologics.
One of the world's biggest pharmaceutical companies is set to get even larger. Pfizer announced on 26 January that it intends to acquire Wyeth, a company with a strong reputation in biologics and vaccines.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
"We obviously have learned a lot from our prior acquisitions,": Like how to win managerial power struggles.